Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

FRA:BC8 - Deutsche Boerse Ag - DE0005158703 - Common Stock - Currency: EUR

39.4  -1.24 (-3.05%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BC8. BC8 was compared to 70 industry peers in the IT Services industry. BC8 has an excellent financial health rating, but there are some minor concerns on its profitability. BC8 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BC8 was profitable.
In the past year BC8 had a positive cash flow from operations.
BC8 had positive earnings in each of the past 5 years.
Each year in the past 5 years BC8 had a positive operating cash flow.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

BC8 has a Return On Assets of 6.54%. This is in the better half of the industry: BC8 outperforms 70.67% of its industry peers.
BC8 has a better Return On Equity (13.65%) than 64.00% of its industry peers.
BC8 has a Return On Invested Capital of 9.60%. This is in the better half of the industry: BC8 outperforms 62.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BC8 is in line with the industry average of 11.01%.
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROIC 9.6%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

BC8 has a Profit Margin of 3.92%. This is comparable to the rest of the industry: BC8 outperforms 54.67% of its industry peers.
In the last couple of years the Profit Margin of BC8 has grown nicely.
With a Operating Margin value of 5.61%, BC8 perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
In the last couple of years the Operating Margin of BC8 has grown nicely.
BC8 has a Gross Margin of 17.71%. This is in the lower half of the industry: BC8 underperforms 77.33% of its industry peers.
In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BC8 is creating value.
BC8 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BC8 has about the same amount of shares outstanding.
The debt/assets ratio for BC8 is higher compared to a year ago.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 4.44 indicates that BC8 is not in any danger for bankruptcy at the moment.
BC8 has a better Altman-Z score (4.44) than 90.67% of its industry peers.
The Debt to FCF ratio of BC8 is 1.17, which is an excellent value as it means it would take BC8, only 1.17 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BC8 (1.17) is better than 85.33% of its industry peers.
BC8 has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
BC8 has a Debt to Equity ratio of 0.29. This is in the better half of the industry: BC8 outperforms 65.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Altman-Z 4.44
ROIC/WACC1.47
WACC6.52%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

BC8 has a Current Ratio of 2.00. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 2.00, BC8 belongs to the best of the industry, outperforming 85.33% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that BC8 should not have too much problems paying its short term obligations.
BC8 has a better Quick ratio (1.64) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.64
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The earnings per share for BC8 have decreased by -3.86% in the last year.
The Earnings Per Share has been growing by 14.31% on average over the past years. This is quite good.
BC8 shows a small growth in Revenue. In the last year, the Revenue has grown by 1.42%.
BC8 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.24% yearly.
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%

3.2 Future

BC8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.52% yearly.
Based on estimates for the next years, BC8 will show a small growth in Revenue. The Revenue will grow by 3.63% on average per year.
EPS Next Y-7.28%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
EPS Next 5YN/A
Revenue Next Year-0.79%
Revenue Next 2Y1.9%
Revenue Next 3Y3.29%
Revenue Next 5Y3.63%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

BC8 is valuated rather expensively with a Price/Earnings ratio of 19.80.
Compared to the rest of the industry, the Price/Earnings ratio of BC8 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 29.35. BC8 is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 19.05, the valuation of BC8 can be described as rather expensive.
BC8's Price/Forward Earnings is on the same level as the industry average.
BC8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.8
Fwd PE 19.05
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BC8's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, BC8 is valued a bit cheaper than 65.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 10.1
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The decent profitability rating of BC8 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.38
EPS Next 2Y-1.22%
EPS Next 3Y2.52%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 1.72%.
Compared to an average industry Dividend Yield of 4.29, BC8 has a dividend in line with its industry peers.
BC8's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

The dividend of BC8 is nicely growing with an annual growth rate of 16.72%!
Dividend Growth(5Y)16.72%
Div Incr Years4
Div Non Decr Years5
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 35.25% of its income as dividend. This is a sustainable payout ratio.
BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP35.25%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (3/7/2025, 7:00:00 PM)

39.4

-1.24 (-3.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)10-22 2024-10-22/bmo
Earnings (Next)03-14 2025-03-14/amc
Inst Owners41.11%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.96B
Analysts77
Price Target42.91 (8.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend0.65
Dividend Growth(5Y)16.72%
DP35.25%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.81%
Min EPS beat(2)-9.76%
Max EPS beat(2)-3.86%
EPS beat(4)1
Avg EPS beat(4)-4.3%
Min EPS beat(4)-9.76%
Max EPS beat(4)0.13%
EPS beat(8)2
Avg EPS beat(8)-1.99%
EPS beat(12)5
Avg EPS beat(12)-0.27%
EPS beat(16)9
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-7.83%
Min Revenue beat(2)-16.2%
Max Revenue beat(2)0.55%
Revenue beat(4)2
Avg Revenue beat(4)-4.92%
Min Revenue beat(4)-16.2%
Max Revenue beat(4)1.78%
Revenue beat(8)4
Avg Revenue beat(8)0.03%
Revenue beat(12)6
Avg Revenue beat(12)-4.82%
Revenue beat(16)6
Avg Revenue beat(16)-8.95%
PT rev (1m)-0.79%
PT rev (3m)-2.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.67%
EPS NY rev (1m)-0.43%
EPS NY rev (3m)-4.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.04%
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE 19.8
Fwd PE 19.05
P/S 0.78
P/FCF 10.66
P/OCF 8.89
P/B 2.71
P/tB 5.44
EV/EBITDA 10.1
EPS(TTM)1.99
EY5.05%
EPS(NY)2.07
Fwd EY5.25%
FCF(TTM)3.7
FCFY9.38%
OCF(TTM)4.43
OCFY11.24%
SpS50.67
BVpS14.55
TBVpS7.25
PEG (NY)N/A
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 6.54%
ROE 13.65%
ROCE 13.47%
ROIC 9.6%
ROICexc 11.94%
ROICexgc 20.94%
OM 5.61%
PM (TTM) 3.92%
GM 17.71%
FCFM 7.3%
ROA(3y)7.31%
ROA(5y)7.24%
ROE(3y)16.22%
ROE(5y)16.41%
ROIC(3y)12.71%
ROIC(5y)12.08%
ROICexc(3y)16.48%
ROICexc(5y)15.47%
ROICexgc(3y)28.38%
ROICexgc(5y)26.41%
ROCE(3y)17.83%
ROCE(5y)16.95%
ROICexcg growth 3Y-0.97%
ROICexcg growth 5Y2.09%
ROICexc growth 3Y-0.91%
ROICexc growth 5Y2.57%
OM growth 3Y5.1%
OM growth 5Y7.51%
PM growth 3Y2.73%
PM growth 5Y5.44%
GM growth 3Y0.99%
GM growth 5Y3.27%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.17
Debt/EBITDA 1.07
Cap/Depr 68.2%
Cap/Sales 1.45%
Interest Coverage 21.82
Cash Conversion 113.05%
Profit Quality 186.2%
Current Ratio 2
Quick Ratio 1.64
Altman-Z 4.44
F-Score5
WACC6.52%
ROIC/WACC1.47
Cap/Depr(3y)69.79%
Cap/Depr(5y)66.81%
Cap/Sales(3y)1.34%
Cap/Sales(5y)1.25%
Profit Quality(3y)82.15%
Profit Quality(5y)91.52%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y11.57%
EPS 5Y14.31%
EPS Q2Q%-16.98%
EPS Next Y-7.28%
EPS Next 2Y-1.22%
EPS Next 3Y2.52%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y8.34%
Revenue growth 5Y8.24%
Sales Q2Q%2.17%
Revenue Next Year-0.79%
Revenue Next 2Y1.9%
Revenue Next 3Y3.29%
Revenue Next 5Y3.63%
EBIT growth 1Y-4.28%
EBIT growth 3Y13.87%
EBIT growth 5Y16.36%
EBIT Next Year27.28%
EBIT Next 3Y13.41%
EBIT Next 5Y10.1%
FCF growth 1Y1190.54%
FCF growth 3Y12.48%
FCF growth 5Y33.59%
OCF growth 1Y1895.19%
OCF growth 3Y13.08%
OCF growth 5Y26.71%